Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer. An analysis of triple therapy versus two dual therapy alternatives

Recent research has focused on eradication therapy as the principal treatment of patients with duodenal ulcers and Helicobacter pylori infection. The aim of this study was to analyse the cost effectiveness of triple therapy versus 2 dual therapies. A health economic evaluation of triple therapy with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 1999-09, Vol.16 (3), p.297-306
Hauptverfasser:	Tennvall, G R, Norinder, A, Ohlin, B
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Adult Aged Aged, 80 and over Amoxicillin Amoxicillin - economics Amoxicillin - therapeutic use Anti-Ulcer Agents - economics Anti-Ulcer Agents - therapeutic use Antibacterials Antiulcers Clarithromycin Cost-Benefit Analysis Cost-effectiveness Drug Therapy, Combination Duodenal Ulcer - drug therapy Duodenal Ulcer - economics Duodenal Ulcer - microbiology Duodenal-ulcer Female Health technology assessment Helicobacter Infections - drug therapy Helicobacter Infections - economics Helicobacter Infections - microbiology Helicobacter pylori Helicobacter-pylori-infections Humans Lansoprazole Male Middle Aged Omeprazole Omeprazole - analogs & derivatives Omeprazole - economics Omeprazole - therapeutic use Penicillins - economics Penicillins - therapeutic use Pharmacoeconomics Randomised-controlled-trials
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!